The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Artificial Heart Valve-Global Market Insights and Sales Trends 2024
Synopsis
An artificial heart valve is a device implanted into the heart of a patient to replace a dysfunctional native heart valve (valvular heart disease).
The global Artificial Heart Valve market size is expected to reach US$ 18630 million by 2029, growing at a CAGR of 11.2% from 2023 to 2029. The market is mainly driven by the significant applications of Artificial Heart Valve in various end use industries. The expanding demands from the Hospital and Clinic, are propelling Artificial Heart Valve market. Transcatheter Heart Valves, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Tissue Heart Valves segment is estimated at % CAGR for the next seven-year period.
Artificial heart valves are medical devices designed to replace damaged or diseased natural heart valves, restoring normal blood flow and improving cardiac function. Several factors are driving the growth of the artificial heart valve market. Firstly, the increasing prevalence of cardiovascular diseases, such as valvular heart disease, is contributing to the rising demand for artificial heart valves. The aging population, sedentary lifestyles, and unhealthy dietary habits have led to a higher incidence of heart valve disorders, creating a significant patient population in need of valve replacement. Secondly, technological advancements in heart valve technologies have significantly improved the performance and durability of artificial valves. The development of bioprosthetic valves, mechanical valves, and transcatheter heart valves has enhanced treatment options and provided better outcomes for patients. These advancements have also led to the minimally invasive implantation of heart valves, reducing the risks associated with traditional open-heart surgeries.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Artificial Heart Valve, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Artificial Heart Valve market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Artificial Heart Valve market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Artificial Heart Valve sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Artificial Heart Valve covered in this report include Edwards Lifesciences, Medtronic, Abbott, Boston Scientific Corporation, LivaNova, Symetis, Jenavalve Technology, Cryolife and TTK Healthcare Limited, etc.
The global Artificial Heart Valve market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Edwards Lifesciences
Medtronic
Abbott
Boston Scientific Corporation
LivaNova
Symetis
Jenavalve Technology
Cryolife
TTK Healthcare Limited
Colibri Heart Valve
Lepu Medical Technology
Braile Biomédica
Micro Interventional
Global Artificial Heart Valve market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Artificial Heart Valve market, Segment by Type:
Transcatheter Heart Valves
Tissue Heart Valves
Mechanical Heart Valves
Global Artificial Heart Valve market, by Application
Hospital
Clinic
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Artificial Heart Valve manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Artificial Heart Valve in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
An artificial heart valve is a device implanted into the heart of a patient to replace a dysfunctional native heart valve (valvular heart disease).
The global Artificial Heart Valve market size is expected to reach US$ 18630 million by 2029, growing at a CAGR of 11.2% from 2023 to 2029. The market is mainly driven by the significant applications of Artificial Heart Valve in various end use industries. The expanding demands from the Hospital and Clinic, are propelling Artificial Heart Valve market. Transcatheter Heart Valves, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Tissue Heart Valves segment is estimated at % CAGR for the next seven-year period.
Artificial heart valves are medical devices designed to replace damaged or diseased natural heart valves, restoring normal blood flow and improving cardiac function. Several factors are driving the growth of the artificial heart valve market. Firstly, the increasing prevalence of cardiovascular diseases, such as valvular heart disease, is contributing to the rising demand for artificial heart valves. The aging population, sedentary lifestyles, and unhealthy dietary habits have led to a higher incidence of heart valve disorders, creating a significant patient population in need of valve replacement. Secondly, technological advancements in heart valve technologies have significantly improved the performance and durability of artificial valves. The development of bioprosthetic valves, mechanical valves, and transcatheter heart valves has enhanced treatment options and provided better outcomes for patients. These advancements have also led to the minimally invasive implantation of heart valves, reducing the risks associated with traditional open-heart surgeries.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Artificial Heart Valve, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Artificial Heart Valve market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Artificial Heart Valve market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Artificial Heart Valve sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Artificial Heart Valve covered in this report include Edwards Lifesciences, Medtronic, Abbott, Boston Scientific Corporation, LivaNova, Symetis, Jenavalve Technology, Cryolife and TTK Healthcare Limited, etc.
The global Artificial Heart Valve market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Edwards Lifesciences
Medtronic
Abbott
Boston Scientific Corporation
LivaNova
Symetis
Jenavalve Technology
Cryolife
TTK Healthcare Limited
Colibri Heart Valve
Lepu Medical Technology
Braile Biomédica
Micro Interventional
Global Artificial Heart Valve market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Artificial Heart Valve market, Segment by Type:
Transcatheter Heart Valves
Tissue Heart Valves
Mechanical Heart Valves
Global Artificial Heart Valve market, by Application
Hospital
Clinic
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Artificial Heart Valve manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Artificial Heart Valve in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Artificial Heart Valve Market Overview
1.1 Artificial Heart Valve Product Overview
1.2 Artificial Heart Valve Market Segment by Type
1.2.1 Transcatheter Heart Valves
1.2.2 Tissue Heart Valves
1.2.3 Mechanical Heart Valves
1.3 Global Artificial Heart Valve Market Size by Type
1.3.1 Global Artificial Heart Valve Market Size Overview by Type (2018-2029)
1.3.2 Global Artificial Heart Valve Historic Market Size Review by Type (2018-2023)
1.3.3 Global Artificial Heart Valve Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Artificial Heart Valve Sales Breakdown by Type (2018-2023)
1.4.2 Europe Artificial Heart Valve Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Artificial Heart Valve Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Artificial Heart Valve Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Artificial Heart Valve Sales Breakdown by Type (2018-2023)
2 Global Artificial Heart Valve Market Competition by Company
2.1 Global Top Players by Artificial Heart Valve Sales (2018-2023)
2.2 Global Top Players by Artificial Heart Valve Revenue (2018-2023)
2.3 Global Top Players by Artificial Heart Valve Price (2018-2023)
2.4 Global Top Manufacturers Artificial Heart Valve Manufacturing Base Distribution, Sales Area, Product Type
2.5 Artificial Heart Valve Market Competitive Situation and Trends
2.5.1 Artificial Heart Valve Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Artificial Heart Valve Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Artificial Heart Valve as of 2022)
2.7 Date of Key Manufacturers Enter into Artificial Heart Valve Market
2.8 Key Manufacturers Artificial Heart Valve Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Artificial Heart Valve Status and Outlook by Region
3.1 Global Artificial Heart Valve Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Artificial Heart Valve Historic Market Size by Region
3.2.1 Global Artificial Heart Valve Sales in Volume by Region (2018-2023)
3.2.2 Global Artificial Heart Valve Sales in Value by Region (2018-2023)
3.2.3 Global Artificial Heart Valve Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Artificial Heart Valve Forecasted Market Size by Region
3.3.1 Global Artificial Heart Valve Sales in Volume by Region (2024-2029)
3.3.2 Global Artificial Heart Valve Sales in Value by Region (2024-2029)
3.3.3 Global Artificial Heart Valve Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Artificial Heart Valve by Application
4.1 Artificial Heart Valve Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.2 Global Artificial Heart Valve Market Size by Application
4.2.1 Global Artificial Heart Valve Market Size Overview by Application (2018-2029)
4.2.2 Global Artificial Heart Valve Historic Market Size Review by Application (2018-2023)
4.2.3 Global Artificial Heart Valve Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Artificial Heart Valve Sales Breakdown by Application (2018-2023)
4.3.2 Europe Artificial Heart Valve Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Artificial Heart Valve Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Artificial Heart Valve Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Artificial Heart Valve Sales Breakdown by Application (2018-2023)
5 North America Artificial Heart Valve by Country
5.1 North America Artificial Heart Valve Historic Market Size by Country
5.1.1 North America Artificial Heart Valve Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Artificial Heart Valve Sales in Volume by Country (2018-2023)
5.1.3 North America Artificial Heart Valve Sales in Value by Country (2018-2023)
5.2 North America Artificial Heart Valve Forecasted Market Size by Country
5.2.1 North America Artificial Heart Valve Sales in Volume by Country (2024-2029)
5.2.2 North America Artificial Heart Valve Sales in Value by Country (2024-2029)
6 Europe Artificial Heart Valve by Country
6.1 Europe Artificial Heart Valve Historic Market Size by Country
6.1.1 Europe Artificial Heart Valve Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Artificial Heart Valve Sales in Volume by Country (2018-2023)
6.1.3 Europe Artificial Heart Valve Sales in Value by Country (2018-2023)
6.2 Europe Artificial Heart Valve Forecasted Market Size by Country
6.2.1 Europe Artificial Heart Valve Sales in Volume by Country (2024-2029)
6.2.2 Europe Artificial Heart Valve Sales in Value by Country (2024-2029)
7 Asia-Pacific Artificial Heart Valve by Region
7.1 Asia-Pacific Artificial Heart Valve Historic Market Size by Region
7.1.1 Asia-Pacific Artificial Heart Valve Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Artificial Heart Valve Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Artificial Heart Valve Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Artificial Heart Valve Forecasted Market Size by Region
7.2.1 Asia-Pacific Artificial Heart Valve Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Artificial Heart Valve Sales in Value by Region (2024-2029)
8 Latin America Artificial Heart Valve by Country
8.1 Latin America Artificial Heart Valve Historic Market Size by Country
8.1.1 Latin America Artificial Heart Valve Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Artificial Heart Valve Sales in Volume by Country (2018-2023)
8.1.3 Latin America Artificial Heart Valve Sales in Value by Country (2018-2023)
8.2 Latin America Artificial Heart Valve Forecasted Market Size by Country
8.2.1 Latin America Artificial Heart Valve Sales in Volume by Country (2024-2029)
8.2.2 Latin America Artificial Heart Valve Sales in Value by Country (2024-2029)
9 Middle East and Africa Artificial Heart Valve by Country
9.1 Middle East and Africa Artificial Heart Valve Historic Market Size by Country
9.1.1 Middle East and Africa Artificial Heart Valve Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Artificial Heart Valve Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Artificial Heart Valve Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Artificial Heart Valve Forecasted Market Size by Country
9.2.1 Middle East and Africa Artificial Heart Valve Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Artificial Heart Valve Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Edwards Lifesciences
10.1.1 Edwards Lifesciences Company Information
10.1.2 Edwards Lifesciences Introduction and Business Overview
10.1.3 Edwards Lifesciences Artificial Heart Valve Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Edwards Lifesciences Artificial Heart Valve Products Offered
10.1.5 Edwards Lifesciences Recent Development
10.2 Medtronic
10.2.1 Medtronic Company Information
10.2.2 Medtronic Introduction and Business Overview
10.2.3 Medtronic Artificial Heart Valve Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Medtronic Artificial Heart Valve Products Offered
10.2.5 Medtronic Recent Development
10.3 Abbott
10.3.1 Abbott Company Information
10.3.2 Abbott Introduction and Business Overview
10.3.3 Abbott Artificial Heart Valve Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Abbott Artificial Heart Valve Products Offered
10.3.5 Abbott Recent Development
10.4 Boston Scientific Corporation
10.4.1 Boston Scientific Corporation Company Information
10.4.2 Boston Scientific Corporation Introduction and Business Overview
10.4.3 Boston Scientific Corporation Artificial Heart Valve Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Boston Scientific Corporation Artificial Heart Valve Products Offered
10.4.5 Boston Scientific Corporation Recent Development
10.5 LivaNova
10.5.1 LivaNova Company Information
10.5.2 LivaNova Introduction and Business Overview
10.5.3 LivaNova Artificial Heart Valve Sales, Revenue and Gross Margin (2018-2023)
10.5.4 LivaNova Artificial Heart Valve Products Offered
10.5.5 LivaNova Recent Development
10.6 Symetis
10.6.1 Symetis Company Information
10.6.2 Symetis Introduction and Business Overview
10.6.3 Symetis Artificial Heart Valve Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Symetis Artificial Heart Valve Products Offered
10.6.5 Symetis Recent Development
10.7 Jenavalve Technology
10.7.1 Jenavalve Technology Company Information
10.7.2 Jenavalve Technology Introduction and Business Overview
10.7.3 Jenavalve Technology Artificial Heart Valve Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Jenavalve Technology Artificial Heart Valve Products Offered
10.7.5 Jenavalve Technology Recent Development
10.8 Cryolife
10.8.1 Cryolife Company Information
10.8.2 Cryolife Introduction and Business Overview
10.8.3 Cryolife Artificial Heart Valve Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Cryolife Artificial Heart Valve Products Offered
10.8.5 Cryolife Recent Development
10.9 TTK Healthcare Limited
10.9.1 TTK Healthcare Limited Company Information
10.9.2 TTK Healthcare Limited Introduction and Business Overview
10.9.3 TTK Healthcare Limited Artificial Heart Valve Sales, Revenue and Gross Margin (2018-2023)
10.9.4 TTK Healthcare Limited Artificial Heart Valve Products Offered
10.9.5 TTK Healthcare Limited Recent Development
10.10 Colibri Heart Valve
10.10.1 Colibri Heart Valve Company Information
10.10.2 Colibri Heart Valve Introduction and Business Overview
10.10.3 Colibri Heart Valve Artificial Heart Valve Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Colibri Heart Valve Artificial Heart Valve Products Offered
10.10.5 Colibri Heart Valve Recent Development
10.11 Lepu Medical Technology
10.11.1 Lepu Medical Technology Company Information
10.11.2 Lepu Medical Technology Introduction and Business Overview
10.11.3 Lepu Medical Technology Artificial Heart Valve Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Lepu Medical Technology Artificial Heart Valve Products Offered
10.11.5 Lepu Medical Technology Recent Development
10.12 Braile Biomédica
10.12.1 Braile Biomédica Company Information
10.12.2 Braile Biomédica Introduction and Business Overview
10.12.3 Braile Biomédica Artificial Heart Valve Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Braile Biomédica Artificial Heart Valve Products Offered
10.12.5 Braile Biomédica Recent Development
10.13 Micro Interventional
10.13.1 Micro Interventional Company Information
10.13.2 Micro Interventional Introduction and Business Overview
10.13.3 Micro Interventional Artificial Heart Valve Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Micro Interventional Artificial Heart Valve Products Offered
10.13.5 Micro Interventional Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Artificial Heart Valve Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Artificial Heart Valve Industrial Chain Analysis
11.4 Artificial Heart Valve Market Dynamics
11.4.1 Artificial Heart Valve Industry Trends
11.4.2 Artificial Heart Valve Market Drivers
11.4.3 Artificial Heart Valve Market Challenges
11.4.4 Artificial Heart Valve Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Artificial Heart Valve Distributors
12.3 Artificial Heart Valve Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
